Anika Therapeutics (ANIK) Change in Taxes (2011 - 2026)
Anika Therapeutics' (ANIK) quarterly Change in Taxes came in at $1.2 million in Q1 2026, up 9253.85% year-on-year from $12722.0 in Q1 2025, and up 255.22% on a QoQ basis from $335000.0 in Q4 2025.
Anika Therapeutics (ANIK) Change in Taxes (2011 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 16 years of Change in Taxes data on file, last reported at $1.2 million in Q1 2026.
- On a quarterly basis, Change in Taxes rose 9253.85% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 90.21% increase from a year earlier, with the FY2025 full-year figure at -$134000.0, down 120.15% from the prior year.
- Change in Taxes for Q1 2026 stood at $1.2 million, up from $335000.0 in the prior quarter.
- Over the last five years, Change in Taxes for ANIK reached as high as $1.3 million in Q2 2022 and fell as low as -$761000.0 in Q2 2024.
- Historically, Change in Taxes has averaged $216941.2 across 5 years, with a median of $90000.0 in 2024.
- Across the five-year window, Change in Taxes tumbled 130.96% in 2023 and jumped 9253.85% in 2026, its largest moves.
- Year by year, Change in Taxes stood at $1.0 million in 2022, then plunged by 58.38% to $422000.0 in 2023, then slumped by 77.01% to $97000.0 in 2024, then jumped by 245.36% to $335000.0 in 2025, then surged by 255.22% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Change in Taxes figures were $1.2 million in Q1 2026, $335000.0 in Q4 2025, and -$21000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 73.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -411.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -463.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 119.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Anika Therapeutics | 198.50 Mn | 131.71 Mn | 19.00 Mn | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.19 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 335,000.00 |
| Dec 31, 2025 | 335,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | -435,000.00 |
| Jun 30, 2025 | -435,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | -761,000.00 |
| Jun 30, 2024 | -761,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Dec 31, 2023 | 422,000.00 |
| Dec 31, 2023 | 422,000.00 |